The Diagnostic and Clinical Significance of TFE3 Immunohistochemical Nuclear Expression in Solitary Fibrous Tumour

Figure 2

Histopathological characteristics of SFTs and the corresponding TFE3 immunohistochemical expression. Routine H&E staining of SFT with “staghorn” vasculature at (a)100x and (b) 400x. Robust TFE3 expression in the corresponding SFT as assessed by immunohistochemistry at (c) 100x and (d) 400x.

(a)

(b)

(c)

(d)